During the past decade, Saltash Health Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saltash Health Center" #1 collaborator was "Encorium" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Saltash Health Center" are "Dyslipidemia" (2 trials), "Hypercholesterolemia" (2 trials), "Allergic Rhinoconjunctivitis" (1 trials), "Cardiovascular Disease" (1 trials) and "Dyslipidemias" (1 trials). Many other conditions were trialed in "Saltash Health Center" in a lesser frequency.

Most popular intervention types in "Saltash Health Center" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pitavastatin" (4 trials), "AST-726 High dose" (1 trials), "AST-726 Low dose" (1 trials), "AST-726 Placebo" (1 trials) and "Angiotensin Therapeutic Vaccine plus CoVaccine HT™ adjuvant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saltash Health Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Saltash Health Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Saltash Health Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saltash Health Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".